<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-91e9c5c4=""><div class="content_outer_container" data-v-91e9c5c4=""><div class="share_preview_container" data-v-91e9c5c4=""><div class="dialog_list" data-v-91e9c5c4=""><div class="dialog_item" data-v-91e9c5c4=""><div class="dialog_question fir_dialog_question" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""><h1 class="fir_question_content" data-v-91e9c5c4="">
                                    How does ELV's Q2 2024 performance compare to peers?
                                </h1> <div class="user_slot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-91e9c5c4=""> <span class="user_desction" data-v-91e9c5c4="">
                                        
                                        3/29/2025 02:34pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-91e9c5c4="">Elevance Health Inc. (ELV) demonstrated a robust performance in Q2 2024 compared to its peers, Molina Healthcare (MOH), Healthequity (HQY), and Alignment Healthcare (ALHC), as evidenced by key financial metrics:

1. **Earnings Per Share (EPS)**:
 - ELV's EPS was $9.85, which is significantly higher than Molina Healthcare's $5.17 and Alignment Healthcare's -$0.13. Healthequity's EPS was $0.33.
2. **Revenue**:
 - ELV generated total revenue of $43.89 billion, substantially more than Molina Healthcare's $9.88 billion and Alignment Healthcare's $681.29 million. Healthequity reported revenue of $287.6 million.
3. **Return on Equity (ROE)**:
 - ELV boasted an ROE of 11.16%, which is higher than Molina Healthcare's 13.29% and significantly better than Alignment Healthcare's -50.26%. Healthequity's ROE was 1.39%.
 
Overall, ELV's Q2 2024 performance showcases strong financial strength and operational efficiency compared to its industry peers.</div> <div class="dialog_answer" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""> <div class="answer_robot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/AIme.ae832fb.png" alt="robot" class="avatar" data-v-91e9c5c4=""> <div class="user_name" data-v-91e9c5c4=""></div></div> <div class="question_content" data-v-91e9c5c4=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-4e97ba8a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-4e97ba8a=""> <div class="recommend-part" data-v-7790c618="" data-v-4e97ba8a=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:H,comeFrom:"AInvestShareLink",events:[],answerSource:s}],fetch:{},error:i,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:x,agent_id:a,output_media_info:[],task_id:a,language:a,source:s,cache_builder:a,reply_action:"Answer",execute_mode:y,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How does ELV's Q2 2024 performance compare to peers?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How does ELV's Q2 2024 performance compare to peers?\",\"user_id\":\"dp58386060\",\"user_name\":\"\",\"trace_id\":\"c2c6bb58-55c8-4d8c-8902-4793559f2e9f\",\"session_id\":\"c2c6bb58-55c8-4d8c-8902-4793559f2e9f\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:z,text:"4 results found:\n|stock code|stock name|Last Price|Last Change|Diluted EPS[20240630]|Total Revenue[20240630]|ROE(Average)[20240630]|Report End Date[20240630]|Report End Date[20250331]|\n|---|---|---|---|---|---|---|---|---|\n|ELV|Elevance Health|$432|0.01%|$9.85|$43.89 billion|11.16%|20240630||\n|MOH|Molina Healthcare|$322.85|-0.19%|$5.17|$9.88 billion|13.29%|20240630||\n|HQY|Healthequity|$86.96|-2.11%|$0.33|$287.6 million|1.39%||20240430|\n|ALHC|Alignment Healthcare|$18.3|0.94%|-$0.13|$681.29 million|-50.26%|20240630||\n",query_data:{number:I,title:A,query_type:z,condition:a,model_sql:J,data_ext_params:{merge_repeat:c,expand_index:b,data_add:x,add_index:e}}}],answer_chain_name:K,native_answer:a,come_from:a,text_answer:H,trace_id:j,cost:20685,event_names:a,question:g,fallback_type:L,input_type:"typewrite",fall_back_reason:{fall_back_type:L,risk_detail:{matched_words:[]}},session_id:j,first_return_cost:2764,cache_type:a,question_id:j,transfer_question:g,signal_type:"ON_COMPLETE",start_time:M,remote_svc:s,slots:[],answer_type:y,user_id:B,skill_name:C},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:B,question:g,source:s,raw_question:g,version:"3.4.1",action_name:C,nlu:{entity:[{type:k,value:"ELV.N",market:D}]},deep_research:c,deep_thinking:c,agent_mode:"normal_agent"},extra:{}},{answer_path:l,section:{id:m,info_texts:["Thinking"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:l,section:{id:m,info_texts:["Searching Web: Elevance Health peers"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:N},logs:[],extra:{action:"Searching Web",action_input:"Elevance Health peers",thought:"The user wants to compare ELV's Q2 2024 performance with its peers. I should focus on identifying key peers and analyzing their Q2 2024 performance. I will use Search to identify ELV's peers. Then, I will use FinQuery for the Q2 2024 performance of ELV and its identified peers."}},{answer_path:d,section:{id:E,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Querying Stock: ELV, Molina Healthcare, HealthEquity, Alignment Healthcare Q2 2024 EPS, Revenue, ROE"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:N},logs:[],extra:{action:"Querying Stock",action_input:A,thought:"I have identified ELV's peers, including Molina Healthcare, HealthEquity, and Alignment Healthcare. Since comparison is needed, Now I will use FinQuery to query the Q2 2024 performance of ELV and these peers together."}},{answer_path:d,section:{id:E,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:E,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Generating Answer"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:f,info_texts:[],show_type:u,voice_txt:"E",text_answer:O,rich_text:O,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"ELV",market_id:D,name:P,domain:k},pos:e,section_id:f,txt:P,jump_type:v},{stock_info:{code:"MOH",market_id:D,name:Q,domain:k},pos:95,section_id:f,txt:Q,jump_type:v},{stock_info:{code:"HQY",market_id:R,name:S,domain:k},pos:120,section_id:f,txt:S,jump_type:v},{stock_info:{code:"ALHC",market_id:R,name:T,domain:k},pos:144,section_id:f,txt:T,jump_type:v}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:f,info_texts:[],show_type:u,voice_txt:".",text_answer:U,rich_text:U,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:u,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:A,query_type:z,trace_data:a,index:I,model_sql:J,data_ext_params:{merge_repeat:c,expand_index:b,data_add:x,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:f,info_texts:[],show_type:u,voice_txt:".\n2",text_answer:V,rich_text:V,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:l,section:{id:m,info_texts:["Completed"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:o,query_text:o,trace_info:{item_id:"ebaaef66b10c96531fce0aa01c0e1792",item_type:h,item_name:o,rec_info:W}},{display_text:p,query_text:p,trace_info:{item_id:"29d16f849eb40e786fd0307dbc073dae",item_type:h,item_name:p,rec_info:X}},{display_text:q,query_text:q,trace_info:{item_id:"5b86f314497cffa8d09f318dd9a46929",item_type:h,item_name:q,rec_info:Y}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:Z,related_name:_}],puuid:F,tag:a,category:"custom",uuid:$}],global:{urp_static_data:[{name:_,value:{status_code:e,columns:[{type:r,index_name:aa,key:aa},{type:r,index_name:ab,key:ab},{type:r,index_name:ac,key:ac},{type:r,index_name:ad,key:ad},{type:r,index_name:ae,key:ae}],datas:[{send_text:o,item_type:h,rec_info:W,display_text:o,rec_reason:a},{send_text:p,item_type:h,rec_info:X,display_text:p,rec_reason:a},{send_text:q,item_type:h,rec_info:Y,display_text:q,rec_reason:a}],dataSize:Z,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:af,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:w,"min-height":"100%",position:ag,height:w},isMaterial:c,id:af,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:G,componentUuid:$,script:[{name:ah,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:G,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:G},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:w,position:ag,height:w},isMaterial:b,_id:19,id:ah,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ai,voice_txt:a,tracking_info:{},uuid:F},order:{is_auto:c,render_for:ai,chart_type:"command",puuid:F}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:C,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:y,answer_chain_name:K},is_deep_research:c,deep_thinking:c,create_time:1743230119359},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:i,docsData:[],quoteData:i},tplType:"question"},events:[],agentId:a}],userId:B,userName:a,startTime:M,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:i,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],traceTableData:i,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Felvs-q2-2024-performance-compare-peers-6a1e68\u002F",config:{_app:{basePath:aj,assetsPath:aj,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,2001,"How does ELV's Q2 2024 performance compare to peers?","llm_generated",null,"c2c6bb58-55c8-4d8c-8902-4793559f2e9f","stock","progress\u002Fsearching_for",1000,"searching_for","📈 What is the current technical analysis of ELV's stock?","🎯 What are the industry trends relevant to ELV's Q2 2024 results?","🌱 How do analysts rate ELV's Q2 2024 performance?","STR","ths_ainvest_lite_web","signal","rich_text","pos_fenshi","auto",1,"agent","intusstock","ELV, Molina Healthcare, HealthEquity, Alignment Healthcare Q2 2024 EPS, Revenue, ROE","dp58386060","review stocks","169",999,"39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Elevance Health Inc. (ELV) demonstrated a robust performance in Q2 2024 compared to its peers, Molina Healthcare (MOH), Healthequity (HQY), and Alignment Healthcare (ALHC), as evidenced by key financial metrics:\n\n1. **Earnings Per Share (EPS)**:\n - ELV's EPS was $9.85, which is significantly higher than Molina Healthcare's $5.17 and Alignment Healthcare's -$0.13. Healthequity's EPS was $0.33.\n2. **Revenue**:\n - ELV generated total revenue of $43.89 billion, substantially more than Molina Healthcare's $9.88 billion and Alignment Healthcare's $681.29 million. Healthequity reported revenue of $287.6 million.\n3. **Return on Equity (ROE)**:\n - ELV boasted an ROE of 11.16%, which is higher than Molina Healthcare's 13.29% and significantly better than Alignment Healthcare's -50.26%. Healthequity's ROE was 1.39%.\n \nOverall, ELV's Q2 2024 performance showcases strong financial strength and operational efficiency compared to its industry peers.",6,"select   stock_code,   diluted_eps,   total_revenue,   roe from   ustock_fin_data where   report_end_date = date('2024y2q')   and stock_code in ('ELV.N', 'MOH.N', 'HQY.O', 'ALHC.O')","agent_common_v2\nagent-summary","NONE",1743230098674,"thinking","Elevance Health Inc. (ELV) demonstrated a robust performance in Q2 2024 compared to its peers, Molina Healthcare (MOH), Healthequity (HQY), and Alignment Healthcare (ALHC), as evidenced by key financial metrics:\n\n1","Elevance Health","Molina Healthcare","185","Healthequity","Alignment Healthcare",". **Earnings Per Share (EPS)**:\n   - ELV's EPS was $9.85, which is significantly higher than Molina Healthcare's $5.17 and Alignment Healthcare's -$0.13. Healthequity's EPS was $0.33[^6]",".\n2. **Revenue**:\n   - ELV generated total revenue of $43.89 billion, substantially more than Molina Healthcare's $9.88 billion and Alignment Healthcare's $681.29 million. Healthequity reported revenue of $287.6 million[^6].\n3. **Return on Equity (ROE)**:\n   - ELV boasted an ROE of 11.16%, which is higher than Molina Healthcare's 13.29% and significantly better than Alignment Healthcare's -50.26%. Healthequity's ROE was 1.39%[^6].\n   \nOverall, ELV's Q2 2024 performance showcases strong financial strength and operational efficiency compared to its industry peers.","2+698_496_21_554+0+0+c2c6bb58-55c8-4d8c-8902-4793559f2e9f+ebaaef66b10c96531fce0aa01c0e1792+llm_generated+aimeTagAnalysis+0+0.06285283714532852+1","2+698_496_21_554+0+0+c2c6bb58-55c8-4d8c-8902-4793559f2e9f+29d16f849eb40e786fd0307dbc073dae+llm_generated+aimeTagAnalysis+0+0.02847391925752163+2","2+698_496_21_554+0+0+c2c6bb58-55c8-4d8c-8902-4793559f2e9f+5b86f314497cffa8d09f318dd9a46929+llm_generated+aimeTagAnalysis+0+0.025005005300045013+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc","\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/195837b.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/e402278.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7c15041.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/69a864a.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/9579193.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/6726d3c.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/c69ce63.js" defer=""></script>